Table 3.

Per participant evaluation results, for participants with seizures recorded. The 3 totals given for the test set are (1) the total across the test set participants with seizures recorded (N=2), (2) the total when including all patients with epilepsy recruited at the London site with data recorded (not listed, N=31), and (3) the total when excluding 1 participant with an artificially disproportionate number of false positives (N=30).

Participant ID			Sensitivity, n (%)		FPa, n		FARb (per 24 hours)		PPVc (%)		Recording length (hours), n		Seizure type
Training set
	FR1	1 (100)		0		0		100		59.6		sGTCSd
	FR2	1 (100)		6		1.56		14		92		sGTCS
	FR3	2 (100)		0		0		100		35.5		GTCSe
	FR4	1 (100)		2		1.34		33		35.8		sGTCS
	FR5	1 (100)		0		0		100		36.3		sGTCS
	FR6	1 (100)		0		0		100		88.5		sGTCS
	FR7	1 (100)		0		0		100		40.7		sGTCS
	FR8	2 (100)		0		0		100		26.2		sGTCS
	Total	10 (100)		8		0.46		56		414.7		N/Af
Test set
	FR9	9 (100)		0		0		100		112.2		sGTCS
	LO1	1 (50)		0		0		100		85.7		sGTCS
	Total (1)	10 (91)		0		0		100		197.9		N/A
	Total (2)	10 (91)		30		0.37		25		1935.9		N/A
	Total (3)	10 (91)		15		0.19		40		1870.3		N/A

^aFP: false positive.

^bFAR: false alarm rate.

^cPPV: positive predictive value.

^dsGTCS: focal to bilateral tonic-clonic seizure.

^eGTCS: generalized tonic-clonic seizure.

^fN/A: not applicable.